Tag Archive for: Investment

Armed with a pipeline of obesity and diabetes hopefuls, Carmot Therapeutics joins the small group of biotechs to attempt a Nasdaq debut this year.

The project will be fully funded by the medicines giant, which has seen surging demand for its diabetes drug Mounjaro, now also being used off-label for weight loss, according to sources familiar with the matter.

Executives from Israel-based companies express concern about future investment and other operational impacts, as the war rages on in Gaza with tragic loss of life amid political and economic uncertainties.

Biopharma companies buying stock in one another did not used to be an unusual practice, but experts told BioSpace this is becoming less common due to greater market volatility.

Seeking to deepen its neurology and rare disease pipelines, AstraZeneca’s Alexion has joined forces with Verge Genomics to leverage its artificial intelligence platform in drug discovery and development.

Seed and Series A funding are set to drop this year as investors are looking for more advanced, less risky deals, according to an industry analysis from HSBC.

Flagship, which has stakes in several other biotech companies including Moderna, will invest $50 million in the Pfizer partnership. Its drug discovery initiative, called Pioneering Medicines, will lead the research for new drug molecules.

“Fewer new funds (are) being raised and so we have the opportunity and the advantage of being able to start companies and support our current companies with a tremendous amount of capital,” said Dr. Beth Seidenberg, founding managing director at Westlake Village.

The existing facility produces active pharmaceutical ingredient (API), the main biologically active components of medicines, and will be expanded to produce material for both current and future products.

A small Raleigh-based startup hopes to shake up the chronic obstructive pulmonary disease (COPD) market with a treatment for an underserved target—airway mucus plugs.